Dong Wook Shin, MD, DrPH, MBA, on Thyroid Cancer: Risk of Side Effects
2017 Cancer Survivorship Symposium
Dong Wook Shin, MD, DrPH, MBA, of Seoul National University Cancer Hospital, discusses the risk of coronary heart disease and ischemic stroke in patients with thyroid cancer taking levothyroxine (Abstract 105).
Shawna V. Hudson, PhD, of Rutgers University, discusses a survivorship program designed to improve the quality of life for Hispanic and Latino breast cancer survivors (Abstract 183).
Ann H. Partridge, MD, MPH, of the Dana-Farber Cancer Institute, summarizes a session she co-chaired on the unique issues affecting adolescent and young adult patients, including their psychosocial needs and concerns that clinicians may overlook.
K. Holly Mead, PhD, of George Washington University, discusses specialized survivorship-specific programs, which are gaining prominence, with over 40% of cancer centers in her study providing this type of care (Abstract 1).
Arti Hurria, MD, of City of Hope, discusses the assessment of older patients with cancer.
Angela R. Bradbury, MD, of the University of Pennsylvania, discusses genetic testing, tumor profiling, and the identification of those at increased risk for second cancers.